102
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Current Treatments to Counter Sleep Dysfunction as a Pathogenic Stimulus of Fibromyalgia

Pages 339-346 | Received 03 Feb 2016, Accepted 31 May 2016, Published online: 17 Jun 2016

References

  • Choy E . Fibromyalgia Syndrome (2nd Edition) . Oxford Rheumatology Library , Oxford, UK ( 2015 ).
  • Wolfe F , SmytheHA , YunusMBet al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia . Arthritis Rheum.33 , 160 – 172 ( 1990 ).
  • Burckhardt CS , GoldenbergD , CroffordLet al. Guideline for the management of fibromyalgia syndrome . Pain in Adults and Children. APS Clinical Practice Guideline Series No. 4 . American Pain Society , Glenview, IL, USA ( 2005 ).
  • Carville SF , Arendt-NielsenL , BliddalHet al. EULAR evidence based recommendations for the management of fibromyalgia syndrome . Ann. Rheum. Dis.67 , 536 – 541 ( 2008 ).
  • Häuser W , ThiemeK , TurkDC . Guidelines on the management of fibromyalgia syndrome – a systematic review . Eur. J. Pain14 ( 1 ), 5 – 10 ( 2010 ).
  • Fitzcharles MA , Ste-MariePA , GoldenbergDLet al. Canadian Pain Society and Canadian Rheumatology Association recommendations for rational care of persons with fibromyalgia: a summary report . J. Rheumatol.40 ( 8 ), 1388 – 1893 ( 2013 ).
  • Kleinman L , MannixS , ArnoldLMet al. Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary . Health Qual. Life Outcomes12 , 111 ( 2014 ).
  • Wolfe F , ClauwDJ , FitzcharlesMAet al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity . Arthritis Care Res.62 , 600 – 610 ( 2010 ).
  • Wolfe F , ClauwDJ , FitzcharlesMAet al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia . J. Rheumatol.38 , 1113 – 1122 ( 2011 ).
  • Carville SF , Arendt-NielsenS , BliddalHet al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome . Ann. Rheum. Dis.67 , 536 – 541 ( 2008 ).
  • Häuser W , BernardyK , ÜceylerNet al. Treatment of fibromyalgia syndrome with antidepressants . JAMA301 , 198 – 209 ( 2009 ).
  • Häuser W , PetzkeF , ÜçeylerNet al. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis . Rheumatol. (Oxford)50 , 532 – 543 ( 2011 ).
  • Clauw DJ . Fibromyalgia: a clinical review . JAMA311 ( 15 ), 1547 – 1555 ( 2014 ).
  • Abeles AM , PillingerMH , SolitarBM , AbelesM . Narrative review: the pathophysiology of fibromyalgia . Ann. Intern. Med.146 ( 10 ), 726 – 734 ( 2007 ).
  • Vierck CJ Jr . Mechanisms underlying development of spatially distributed chronic pain (fibromyalgia) . Pain124 ( 3 ), 242 – 263 ( 2006 ).
  • Yunus MB . Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes . Semin. Arthritis Rheum.36 ( 6 ), 339 – 356 ( 2007 ).
  • Gracely RH , GrantMA , GieseckeT . Evoked pain measures in fibromyalgia . Best Pract. Res. Clin. Rheumatol.17 ( 4 ), 593 – 609 ( 2003 ).
  • Staud R , SpaethM . Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia . CNS Spectr.13 ( 3 Suppl. 5 ), 12 – 17 ( 2008 ).
  • Granot M , BuskilaD , GranovskyY , SprecherE , NeumannL , YarnitskyD . Simultaneous recording of late and ultra-late pain evoked potentials in fibromyalgia . Clin. Neurophysiol.112 ( 10 ), 1881 – 1887 ( 2001 ).
  • Gracely RH , PetzkeF , WolfJM , ClauwDJ . Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia . Arthritis Rheum.46 , 1333 – 1343 ( 2002 ).
  • Vaeroy H , HelleR , ForreO , KassE , TereniusL . Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis . Pain32 ( 1 ), 21 – 26 ( 1998 ).
  • Russell IJ , OrrMD , LittmanBet al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome . Arthritis Rheum.37 ( 11 ), 1593 – 1601 ( 1994 ).
  • Larson AA , GiovengoSL , RussellIJ , MichalekJE . Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways . Pain87 ( 2 ), 201 – 211 ( 2000 ).
  • Giovengo SL , RussellIJ , LarsonAA . Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia . J. Rheumatol.26 ( 7 ), 1564 – 1569 ( 1999 ).
  • Bradley LA , SotolongoA , AlbertsKRet al. Abnormal regional cerebral blood flow in the caudate nucleus among fibromyalgia patients and non-patients is associated with insidious symptom onset . J. Musculoskel. Pain7 , 285 – 292 ( 1999 ).
  • Mountz JM , BradleyLA , ModellJGet al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels . Arthritis Rheum.38 ( 7 ), 926 – 938 ( 1995 ).
  • Kuchinad A , SchweinhardtP , SeminowiczDA , WoodPB , ChizhBA , BushnellMC . Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain?J. Neurosci.27 ( 15 ), 4004 – 4007 ( 2007 ).
  • Luerding R , WeigandT , BogdahnU , Schmidt-WilckeT . Working memory performance is correlated with local brain morphology in the medial frontal and anterior cingulate cortex in fibromyalgia patients: structural correlates of pain–cognition interaction . Brain131 ( 12 ), 3222 – 3231 ( 2008 ).
  • Lutz J , JagerL , de QuervainDet al. White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study . Arthritis Rheum.58 ( 12 ), 3960 – 3969 ( 2008 ).
  • Sundgren PC , PetrouM , HarrisREet al. Diffusion-weighted and diffusion tensor imaging in fibromyalgia patients: a prospective study of whole brain diffusivity, apparent diffusion coefficient, and fraction anisotropy in different regions of the brain and correlation with symptom severity . Acad. Radiol.14 ( 7 ), 839 – 846 ( 2007 ).
  • Cook DB , LangeG , CicconeDS , LiuWC , SteffenerJ , NatelsonBH . Functional imaging of pain in patients with primary fibromyalgia . J. Rheumatol.31 ( 2 ), 364 – 378 ( 2004 ).
  • Kwiatek R , BarndenL , TedmanRet al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami . Arthritis Rheum.43 ( 12 ), 2823 – 2833 ( 2000 ).
  • Russell IJ , VaeroyH , JavorsM , NybergF . Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis . Arthritis Rheum.35 ( 5 ), 550 – 556 ( 1992 ).
  • Jensen KB , KosekE , PetzkeFet al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain . Pain144 ( 1–2 ), 95 – 100 ( 2009 ).
  • Harris RE , ClauwDJ , ScottDJ , McLeanSA , GracelyRH , ZubietaJK . Decreased central mu-opioid receptor availability in fibromyalgia . J. Neurosci.27 ( 37 ), 10000 – 10006 ( 2007 ).
  • Lautenbacher S , RollmanGB . Possible deficiencies of pain modulation in fibromyalgia . Clin. J. Pain13 ( 3 ), 189 – 196 ( 1997 ).
  • Kosek E , HanssonP . Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects . Pain70 ( 1 ), 41 – 51 ( 1997 ).
  • Julien N , GoffauxP , ArsenaultP , MarchandS . Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition . Pain114 ( 1–2 ), 295 – 302 ( 2005 ).
  • Staud R , RobinsonME , VierckCJJr , PriceDD . Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients . Pain101 ( 1–2 ), 167 – 174 ( 2003 ).
  • Choy EH . The role of delta sleep in pain and fibromyalgia . Nat. Rev. Rheumatol.11 ( 9 ), 513 – 520 ( 2015 ).
  • Moldofsky H , ScarisbrickP . Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation . Psychosom. Med.38 ( 1 ), 35 – 44 ( 1976 ).
  • Bigatti SM , HernandezAM , CronanTA , RandKL . Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression . Arthritis Rheum.59 ( 7 ), 961 – 967 ( 2008 ).
  • Yunus MB , AhlesTA , AldagJC , MasiAT . Relationship of clinical features with psychological status in primary fibromyalgia . Arthritis Rheum.34 ( 1 ), 15 – 21 ( 1991 ).
  • Mork PJ , NilsenTI . Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway . Arthritis Rheum.64 ( 1 ), 281 – 284 ( 2012 ).
  • McBeth J , LaceyRJ , WilkieR . Predictors of new-onset widespread pain in older adults: results from a population-based prospective cohort study in the UK . Arthritis Rheumatol.66 , 757 – 767 ( 2014 ).
  • Tononi G . Slow wave homeostasis and synaptic plasticity . J. Clin. Sleep Med.5 ( 2 Suppl. ), S16 – S19 ( 2009 ).
  • Roizenblatt S , MoldofskyH , Benedito-SilvaAA , TufikS . Alpha sleep characteristics in fibromyalgia . Arthritis Rheum.44 ( 1 ), 222 – 230 ( 2001 ).
  • Lentz MJ , LandisCA , RothermelJ , ShaverJL . Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women . J. Rheumatol.26 ( 7 ), 1586 – 1592 ( 1999 ).
  • Onen SH , AllouiA , GrossA , EschallierA , DubrayC . The effects of total sleep deprivation, selective sleep interruption and sleep recovery on pain tolerance thresholds in healthy subjects . J. Sleep Res.10 ( 1 ), 35 – 42 ( 2001 ).
  • Roehrs T , HydeM , BlaisdellB , GreenwaldM , RothT . Sleep loss and REM sleep loss are hyperalgesic . Sleep29 ( 2 ), 145 – 151 ( 2006 ).
  • Smith MT , EdwardsRR , McCannUD , HaythornthwaiteJA . The effects of sleep deprivation on pain inhibition and spontaneous pain in women . Sleep30 ( 4 ), 494 – 505 ( 2007 ).
  • Paul-Savoie E1 , MarchandS , MorinMet al. Is the deficit in pain inhibition in fibromyalgia influenced by sleep impairments? Open Rheumatol. J. 6 , 296 – 302 ( 2012 ).
  • Dauvilliers Y , BayardS , ShneersonJM , PlazziG , MyersAJ , Garcia-BorregueroD . High pain frequency in narcolepsy with cataplexy . Sleep Med.12 ( 6 ), 572 – 577 ( 2011 ).
  • Perrot S , RussellIJ . More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms . Eur. J. Pain18 ( 8 ), 1067 – 1080 ( 2014 ).
  • Arnold LM , WangF , AhlJ , GaynorPJ , WohlreichMM . Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial . Arthritis Res. Ther.13 ( 3 ), R86 ( 2011 ).
  • Ahmed M , AamirR , JishiZ , ScharfMB . The effects of milnacipran on sleep disturbance in fibromyalgia: a randomized, double-blind, placebo-controlled, two-way crossover study . J. Clin. Sleep Med.12 ( 1 ), 79 – 86 ( 2015 ).
  • Arnold LM , EmirB , PauerL , ResnickM , ClairA . Time to improvement of pain and sleep quality in clinical trials of pregabalin for the treatment of fibromyalgia . Pain Med.16 ( 1 ), 176 – 185 ( 2015 ).
  • Arnold LM , Sarzi-PuttiniP , ArsenaultPet al. Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study . J. Rheumatol.42 ( 7 ), 1237 – 1244 ( 2015 ).
  • Roth T , Bhadra-BrownP , PitmanVW , ResnickEM . Pregabalin improves fibromyalgia-related sleep disturbance . Clin. J. Pain32 ( 4 ), 308 – 312 ( 2015 ).
  • Choy E , MarshallD , GabrielZL , MitchellSA , GyleeE , DakinHA . A systematic review and mixed treatment comparison of the efficacy of pharmacological treatments for fibromyalgia . Semin. Arthritis Rheum.41 ( 3 ), 335 – 345 ( 2011 ).
  • Moldofsky H . Management of sleep disorders in fibromyalgia . Rheum. Dis. Clin. North Am.28 ( 2 ), 353 – 365 ( 2002 ).
  • Blois R , GaillardJM , AttaliP , CoquelinJP . Effect of zolpidem on sleep in healthy subjects: a placebo-controlled trial with polysomnographic recordings . Clin. Ther.15 ( 5 ), 797 – 809 ( 1993 ).
  • Mann K , BauerH , HiemkeC , RöschkeJ , WetzelH , BenkertO . Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion . Eur. Neuropsychopharmacol.6 ( 3 ), 163 – 168 ( 1996 ).
  • Moldofsky H , LueFA , MouslyC , Roth-SchechterB , ReynoldsWJ . The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study . J. Rheumatol.23 ( 3 ), 529 – 533 ( 1996 ).
  • Grönblad M , NykänenJ , KonttinenY , JärvinenE , HelveT . Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial . Clin. Rheumatol.12 ( 2 ), 186 – 191 ( 1993 ).
  • Mamelak M , BlackJ , MontplaisirJ , RistanovicR . A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy . Sleep27 ( 7 ), 1327 – 1334 ( 2004 ).
  • Russell IJ , PerkinsAT , MichalekJE , Oxybate SXB-26 Fibromyalgia Syndrome Study Group . Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial . Arthritis Rheum.60 ( 1 ), 299 – 309 ( 2009 ).
  • Moldofsky H , InhaberNH , GuintaDR , Alvarez-HorineSB . Effects of sodium oxybate on sleep physiology and sleep/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study . J. Rheumatol.37 ( 10 ), 2156 – 2166 ( 2010 ).
  • Russell IJ , HolmanAJ , SwickTJ , Alvarez-HorineS , WangYG , GuintaD , Sodium Oxybate 06-008 FM Study Group . Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study . Pain152 ( 5 ), 1007 – 1017 ( 2011 ).
  • Spaeth M , BennettRM , BensonBA , WangYG , LaiC , ChoyEH . Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international Phase 3 trial . Ann. Rheum. Dis.71 ( 6 ), 935 – 942 ( 2012 ).
  • Ibrahim F , LaiC , ChoyE . Use of path analysis to evaluate the effects of sodium oxybate on pain reduction in patients with fibromyalgia . Arthritis Rheum.61 ( Suppl. ), Abstract 819 ( 2010 ).
  • Ferracioli-Oda E , QawasmiA , BlochMH . Meta-analysis: melatonin for the treatment of primary sleep disorders . PLoS ONE8 ( 5 ), e63773 ( 2013 ).
  • Vural EM , van MunsterBC , de RooijSE . Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature . Drugs Aging31 ( 6 ), 441 – 451 ( 2014 ).
  • de Zanette SA , VercelinoR , LasteGet al. Melatonin analgesia is associated with improvement of the descending endogenous pain-modulating system in fibromyalgia: a Phase II, randomized, double-dummy, controlled trial . BMC Pharmacol. Toxicol.15 , 40 ( 2014 ).
  • Bennett RM , GatterRA , CampbellSM , AndrewsRP , ClarkSR , ScarolaJA . A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study . Arthritis Rheum.31 ( 12 ), 1535 – 1542 ( 1988 ).
  • Quimby LG , GratwickGM , WhitneyCD , BlockSR . A randomized trial of cyclobenzaprine for the treatment of fibromyalgia . J. Rheumatol. Suppl.19 , 140 – 143 ( 1989 ).
  • Reynolds WJ , MoldofskyH , SaskinP , LueFA . The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia . J. Rheumatol.18 ( 3 ), 452 – 454 ( 1991 ).
  • Carette S , BellMJ , ReynoldsWJet al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial . Arthritis Rheum.37 ( 1 ), 32 – 40 ( 1994 ).
  • Tofferi JK , JacksonJL , O’MalleyPG . Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis . Arthritis Rheum.51 ( 1 ), 9 – 13 ( 2004 ).
  • Moldofsky H , HarrisHW , ArchambaultWT , KwongT , LedermanS . Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study . J. Rheumatol.38 ( 12 ), 2653 – 2663 ( 2011 ).
  • Ware MA , FitzcharlesMA , JosephL , ShirY . The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial . Anesth. Analg.110 ( 2 ), 604 – 610 ( 2010 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.